One out of every four adults in the United States has taken a psychotropic agent in the last year; one out of every two has taken a psychotrope at some time in his life. Since their introduction in the 1950s, the new psychotherapeutic drugs have attained a position of importance in the armamentarium of the physician. Whether the increase in the use of these drugs is the result of "turbulent times," of promotional efforts, or "of sloppy prescribing practices of clinicians is uncertain." There is, however, reason to believe that psychopharmacology will hold a unique position within drug liability in much the same way that the latter has been sui generis within products liability.
Dugan, Thomas P.
"The Legal and Social Implications of Psychopharmacology,"
Hofstra Law Review: Vol. 2
, Article 18.
Available at: https://scholarlycommons.law.hofstra.edu/hlr/vol2/iss2/18